4/24/2015 - 9:52 AM EST - Cipher Pharmaceuticals Inc. : today announced that the Court has issued an opinion in the claim construction hearing for the patent infringement suit by Ranbaxy Inc., Ranbaxy Pharmaceuticals Inc., a Sun Pharma Company, Galephar Pharmaceutical Research Inc., and Cipher against Watson Laboratories, Inc., related to Watson's Abbreviated New Drug Application for a generic version of Absorica® (isotretinoin capsules). Cipher Pharmaceuticals Inc.
shares T.CPH are trading down $0.17 at $13.27.
